The company sources transcranial magnetic stimulation (TMS) devices from Neuronetics, an FDA-regulated medical device supplier. Under the Neuronetics Agreement, the company and Neuronetics collaborate on co-branding, co-marketing, and product development, with minimum purchase commitments and a per-click consumable model for treatment sessions. As of March 31, 2023, the company converted an outstanding payable balance to Neuronetics of approximately $5.7 million into a $6.0 million secured promissory note. The company is piloting a Medication Management Program at select Treatment Centers to support medication management for mental health disorders and to develop an internal patient pipeline for TMS and Spravato® treatments. Additionally, the company is exploring strategic partnerships, acquisitions, and mergers but has not finalized any agreements. In Fiscal 2024, the company began piloting talk therapy services at select Treatment Centers.
Greenbrook Tms Inc's Comment on Supply Chain
The company sources transcranial magnetic stimulation (TMS) devices from Neuronetics, an FDA-regulated medical device supplier. Under the Neuronetics Agreement, the company and Neuronetics collaborate on co-branding, co-marketing, and product development, with minimum purchase commitments and a per-click consumable model for treatment sessions. As of March 31, 2023, the company converted an outstanding payable balance to Neuronetics of approximately $5.7 million into a $6.0 million secured promissory note. The company is piloting a Medication Management Program at select Treatment Centers to support medication management for mental health disorders and to develop an internal patient pipeline for TMS and Spravato® treatments. Additionally, the company is exploring strategic partnerships, acquisitions, and mergers but has not finalized any agreements. In Fiscal 2024, the company began piloting talk therapy services at select Treatment Centers.
Sources:
Greenbrook Tms Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Greenbrook Tms Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
